Open AccessRisk of Kaposi sarcoma during the first months on combination antiretroviral therapy
Author(s) -
JeanMarc Lacombe,
François Boué,
Sophie Grabar,
N. Viget,
S. Gazaignes,
Anne-Sophie Lascaux-Cametz,
Jérôme Pacanowski,
Marialuisa Partisani,
Odile Launay,
Sophie Matheron,
Éric Rosenthal,
É. Rouveix,
Pierre Tattevin,
Pierre de Truchis,
Dominique Costagliola,
James J. Goedert
Publication year - 2013
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32835cba6c
Subject(s) - cart , sarcoma , medicine , poisson regression , incidence (geometry) , kaposi's sarcoma , relative risk , confidence interval , cohort , viral load , gastroenterology , surgery , human immunodeficiency virus (hiv) , immunology , pathology , population , mechanical engineering , physics , human herpesvirus , environmental health , optics , engineering
To determine whether incident AIDS-defining Kaposi sarcoma or Pneumocystis jiroveci pneumonia (PJP) is associated with combination antiretroviral therapy (cART) initiation.